Proteomics International Laboratories Limited announced that it has appointed Mr. John (Chuck) Morrison as the Company's Head of Global Business Development. Mr. Morrison has more than 36 years' experience in the life sciences, biotechnology and diagnostic industries and his appointment represents a key addition to PILL's senior management team. He will play a key role in sourcing and executing commercialisation opportunities for products derived from the Company's proprietary proteomics-based technology platform.

Mr. Morrison has a highly successful track record in executing licensing deals and major acquisitions in the life sciences sector worldwide, including a lead role in the acquisition of Symbio Diagnostics. Based in a major biotech centre and home to several major pharmaceutical companies, in Boston in the USA, Mr. Morrison is well placed to represent PILL in the massive US life sciences and biotech markets and other major markets. He has previously held senior roles at NEN Life Sciences and DuPont, and in business development at PerkinElmer.